Furthermore, examination of CCL2 levels using IHC demonstrated overexpression in the primary tumor as well as in a metastatic lesion of human PDA (Figure 3B), where CCL2 was overexpressed starting in early disease and continued to be expressed highly throughout disease progression (Supplemental Figure 3A). The gene discussed is CCL2; the disease is neoplasm.